Observational Study To Evaluate Patterns Of Prescription In A Psychiatry Outpatient Department In A Tertiary Care Teaching Hospital
Observational Study To Evaluate Patterns Of Prescription In A Psychiatry OPD in Teaching Hospital
Keywords:
Prescription pattern, Psychiatry, Tertiary healthcareAbstract
Objective: To study the prescription patterns in a psychiatry outpatient department in a tertiary care teaching hospital. Methodology: An observational study was conducted from August 2007 to January 2008 in a psychiatry outpatient department in a tertiary care teaching hospital. A total of 300 patients suffering from 3 major classes of psychiatric illnesses (Schizophrenia & other psychotic disorders, Mood disorders, Anxiety disorders as diagnosed by Psychiatrists). The data from the prescription card of the patients was noted in a structured pro forma. Results: Prescription analysis showed that average number of drugs per encounter (Mean ± SD) was 2.53 ± 0.97. Not a single drug was prescribed by generic name. Injection was prescribed in 5% of prescriptions. 67.41% of drugs were prescribed from hospital formulary while 60.03% of drugs were actually dispensed from the hospital pharmacy. In Schizophrenia and other psychotic disorders, most common antipsychotic drug prescribed was Trifluoperazine followed by Chlorpromazine. In mood and anxiety disorders, most common drug prescribed was Imipramine and Chlordiazepoxide respectively. Conclusion: The present study could serve as a platform upon which further studies in prescription analysis of psychotropic drugs can be undertaken to investigate the scope for improvement in prescribing practices in psychiatry. [Goyal SG NJIRM 2016; 7(1):31-36]
References
2. Reus VI. Mental disorders. In: Braunwald E, Fauci AS, Kapser DL, Hauser SL, Longo DL, Jameson JL and Loscalzo J, editors. Harrison’s principles of internal medicine. 17th edition. New York: McGraw-Hill publication; 2008. p. 2710-2723.
3. Champoux N, Monette J, Monette M, Galbaud du Fort G, Wolfson C, Le Cruguel JP. Use of neuroleptics: study of institutionalized elderly people in Montreal, Que. Can Fam Physician. 2005 May; 51:696-7.
4. Simon AE, Peter M, Hess L, Valterio C. Antipsychotic use in patients with schizophrenia treated in private psychiatry. Swiss Med Wkly. 2005 Feb 19; 135(7-8):109-15.
5. Pincus HA, Tanielian TL, Marcus SC, Olfson M, Zarin DA, Thompson J, et al. Prescribing trends inpsychotropic medications: primary care, psychiatry, and other medical specialties. JAMA. 1998 Feb 18; 279(7):526-31.
6. Loosbrock DL, Tomlin ME, Robinson RL, Obenchain RL, Croghan TW. Appropriateness of prescribing practices for serotonergic antidepressants. Psychiatr Serv. 2002 Feb; 53(2):179-84.
7. Olfson M, Marcus SC, Pincus HA. Trends in office-based psychiatric practice. Am J Psychiatry. 1999 Mar; 156(3):451-7.
8. Jankovio SM, Dukio Dejanovio SM. Drug Utilization Trends in Clinical Hospital center “Kragujevac†from 1997 to 1999. Indian J Pharmacol. 2001; 33:29-36.
9. Mond J, Morice R, Owen C. Use of antipsychotic medications in Australian States and Territories between July 1995 and December 2001. Australasian Psychiatry. 2003 Sep; 11(3):267-272.
10. Hermann RC, Yang D, Ettner SL, Marcus SC, Yoon C, Abraham M. Prescription of antipsychotic drugs by office-based physicians in the United States, 1989-1997. Psychiatr Serv. 2002 Apr; 53(4):425-30.
11. Botvinik L, Ng C, Schweitzer I. Audit of antipsychotic prescribing in a private psychiatric hospital. Australasian Psychiatry. 2004 Sep; 12(3):1-7.
12. Redondo Capafons S, Monso Fernandez C, Garriga Biosca MR, Pla Poblador R, Quintana Riera S, Porta Rius G. Use of psychoactive drugs in a health and welfare centre. Farm Hosp. 2007 May-Jun; 31(3):173-6.
13. World Health Organization Action Programme on Essential Drugs. How to investigate drug use in health facilities: selected drug use indicators. Geneva, World Health Organization, 1993; (WHO/DAP/93.1).
14. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric press, 2000.
15. Gupta M, Malhotra S, Jain S, Aggarwal A, Pandhi P. Pattern of prescription of non-steroidal antiinflammatory drugs in orthopaedic outpatient clinic of a North Indian tertiary care hospital. Indian J Pharmacol. 2005; 37(6):404-405.
16. Gupta N, Sharma D, Garg SK, Bhargava VK. Auditing of Prescriptions to study utilization of antimicrobials in a tertiary hospital. Indian J Pharmacol. 1997; 29:411-415.
17. Brüggemann BR, Elgeti H, Ziegenbein M. Patterns of Drug Prescription in a Psychiatric Outpatient Care Unit: The Issue of Polypharmacy. German J Psychiatry. 2008; 11:1-6.
18. Chong MY, Tan CH, Fujii S, Yang SY, Ungvari GS, Si T, et al. Antipsychotic drug prescription for schizophrenia in East Asia: rationale for change. Psychiatry Clin Neurosci. 2004 Feb; 58(1):61-7.
19. Dolder CR, Lacro JP, Dunn LB, Jeste DV. Antipsychotic medication adherence: is there a difference between typical and atypical agents? Am J Psychiatry. 2002 Jan; 159(1):103-8.
20. Cook PE, Goldberg JO, Van Lieshout RJ. Benefits of switching from typical to atypical antipsychotic medications: a longitudinal study in a community-based setting. Can J Psychiatry. 2002 Nov; 47(9):870-4.
21. Mortimer AM, Shepherd CJ, Rymer M, Burrows A. Primary care use of antipsychotic drugs: an audit and intervention study. Ann Gen Psychiatry. 2005 Nov 29; 4:18.
22. Tang YL, Mao PX, Jiang F, Chen Q, Wang CY, Cai ZJ, et al. Clozapine in China. Pharmacopsychiatry. 2008 Jan; 41(1):1-9.
23. Kiivet RA, Llerena A, Dahl ML, Rootslane L, Sanchez Vega J, Eklundh T, et al. Patterns of drug treatment of schizophrenic patients in Estonia, Spain and Sweden. Br J Clin Pharmacol. 1995 Nov; 40(5):467-76.
24. Frank L, Revicki DA, Sorensen SV, Shih YC. The economics of selective serotonin reuptake inhibitors in depression: a critical review. CNS Drugs. 2001 Jan; 15(1):59-83.
25. Balon R, Mufti R, Arfken CL. A survey of prescribing practices for monoamine oxidase inhibitors. Psychiatr Serv. 1999 Jul; 50(7):945-7.
